Can AI help predict which heart-failure patients will worsen within a year?
Researchers at MIT, Mass General Brigham, and Harvard Medical School developed a deep-learning model to forecast a patient’s heart failure prognosis up to a year in advance.
Researchers at MIT, Mass General Brigham, and Harvard Medical School developed a deep-learning model to forecast a patient’s heart failure prognosis up to a year in advance.
Assistant Professor Matthew Jones is working to decode molecular processes on the genetic, epigenetic, and microenvironment levels to anticipate how and when tumors evolve to resist treatment.
From early motion-sensing platforms to environmental monitoring, the professor and head of the Program in Media Arts and Sciences has turned decades of cross-disciplinary research into real-world impact.
The engineered tissue grafts could take on the liver’s function and help thousands of people with liver failure.
By providing holistic information on a cell, an AI-driven method could help scientists better understand disease mechanisms and plan experiments.
In STS.059 (The Bioeconomy and Society), students explore the social and political factors at work in the biology, biotech, and biological engineering sectors.
Based on a virus-like particle built with a DNA scaffold, the approach could generate broadly neutralizing antibody responses against HIV or influenza.
The new system could be used at home or in doctors’ offices to scan people who are at high risk for breast cancer.
Founded by three MIT alumni, Gensaic uses AI-guided protein design to deliver RNA and other therapeutic molecules to specific cells or areas of the body.
Professor, mentor, and leader at MIT for more than 50 years shaped fundamental understandings of cell adhesion, the extracellular matrix, and molecular mechanisms of metastasis.
MIT engineers designed capsules with biodegradable radio frequency antennas that can reveal when the pill has been swallowed.
Nanoparticles coated with molecular sensors could be used to develop at-home tests for many types of cancer.
The MIT senior helps design proteins that spur the immune system to fight cancer and other diseases.
Therapeutic antibodies packaged into microparticles could be injected with a standard syringe, avoiding the need for lengthy and often uncomfortable infusions.
Temporarily anesthetizing the retina briefly reverts the activity of the visual system to that observed in early development and enables growth of responses to the amblyopic (“lazy”) eye.